Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN)

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

July 10, 2020

Study Completion Date

July 10, 2020

Conditions
Metabolism and Nutrition Disorder
Interventions
DIETARY_SUPPLEMENT

Nutrition Therapy

At the time of diagnosis, patients will immediately be screened and started with Nutrition Therapy if assigned to group A. This regimen will stay in place for 6 weeks to 3 months, after which a switch will be made towards normal dietary counselling. Nutrition Therapy can be given orally, parenterally or via tube feeding (enteral nutrition), depending on the patient's status and aims at matching Caloric Intake with Resting Energy Expenditure. Moreover, a switch between these modalities is possible. Afterwards, standard dietary counselling will be given during the remainder of the study. Follow-up will last one year. If 6 months after the last enrolment the study shows a large difference with the control group, the study will be stopped for ethical reasons.

DIETARY_SUPPLEMENT

Control Therapy

At the time of diagnosis, patients will immediately be screened and started with standard dietary counselling for 1 year if assigned to group B. Dietary intervention can be orally, parenterally or via tube feeding (enteral nutrition), depending on the patient's status. Moreover, a switch between these modalities is possible. Follow-up will last 1 year. If 6 months after the last enrolment the study shows a large difference with the control group, the study will be stopped for ethical reasons.

Trial Locations (1)

1090

UZ Brussel, Jette

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

collaborator

Nutricia, Inc.

INDUSTRY

lead

Universitair Ziekenhuis Brussel

OTHER

NCT03058107 - Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN) | Biotech Hunter | Biotech Hunter